Fig 5. Mouse EBOV window study.
(A) The survival curves between pyronaridine 75 mg/kg administered at 2 or 24h post infection were not statistically significantly different using a log-rank (Mantel-Cox) test (p = 0.5567), while pyronaridine administered at 48h was not statistically different than the vehicle (p = 0.7782). B) Mean clinical scoring results with overlaid percent survival. (C) Mean body weight results.